Acorah Software Products - Accounts Production 16.8.310 false true true false 1 May 2024 30 April 2025 30 April 2025 15650277 Mr Paul Rossiter iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15650277 2024-04-30 15650277 2025-04-30 15650277 2024-05-01 2025-04-30 15650277 frs-core:CurrentFinancialInstruments 2025-04-30 15650277 frs-core:ComputerEquipment 2025-04-30 15650277 frs-core:ComputerEquipment 2024-05-01 2025-04-30 15650277 frs-core:ComputerEquipment 2024-04-30 15650277 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-05-01 2025-04-30 15650277 frs-core:OtherResidualIntangibleAssets 2025-04-30 15650277 frs-core:OtherResidualIntangibleAssets 2024-05-01 2025-04-30 15650277 frs-core:OtherResidualIntangibleAssets 2024-04-30 15650277 frs-core:ShareCapital 2025-04-30 15650277 frs-core:RetainedEarningsAccumulatedLosses 2025-04-30 15650277 frs-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 15650277 frs-bus:FilletedAccounts 2024-05-01 2025-04-30 15650277 frs-bus:SmallEntities 2024-05-01 2025-04-30 15650277 frs-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 15650277 frs-bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 15650277 frs-bus:Director1 2024-05-01 2025-04-30 15650277 frs-countries:EnglandWales 2024-05-01 2025-04-30
Registered number: 15650277
Men's Health Engineers Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2025
iLex Accountancy Services Ltd
Unit 1 & 2 Steadings
Maisemore
Gloucester
Gloucestershire
GL2 8EY
Men's Health Engineers Ltd
Contents
Contents

| Page
--- | ---
Company Information | 1
Balance Sheet | 2—3
Notes to the Financial Statements | 4—7

Page 1
Men's Health Engineers Ltd
Company Information
For The Year Ended 30 April 2025
Company Information

Director | Mr Paul Rossiter
Company Number | 15650277
Registered Office | 9 Larkspear Close
| Gloucester
| Gloucestershire
| GL1 5LN
Accountants | iLex Accountancy Services Ltd
| Unit 1 & 2 Steadings
| Maisemore
| Gloucester
| Gloucestershire
| GL2 8EY

Page 1
Page 2
Men's Health Engineers Ltd
Balance Sheet
As At 30 April 2025
Balance Sheet
Registered number: 15650277

| 2025
--- | ---
| Notes | £ | £
FIXED ASSETS
Intangible Assets | 4 |  | 13,746
Tangible Assets | 5 |  | 963
|  |  | 14,709
CURRENT ASSETS
Debtors | 6 | 1,231 |
Cash at bank and in hand |  | 25,374 |
|  | 26,605 |
Creditors: Amounts Falling Due Within One Year | 7 | (33,751 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (7,146 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 7,563
PROVISIONS FOR LIABILITIES
Deferred Taxation |  |  | (212 )
NET ASSETS |  |  | 7,351
CAPITAL AND RESERVES
Called up share capital | 8 |  | 1
Profit and Loss Account |  |  | 7,350
SHAREHOLDERS' FUNDS |  |  | 7,351

Page 2
Page 3
Men's Health Engineers Ltd
Balance Sheet (continued)
As At 30 April 2025
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Paul Rossiter Director
16/12/2025

The notes on pages 4 to 7 form part of these financial statements.
Page 3
Page 4
Men's Health Engineers Ltd
Notes to the Financial Statements
For The Year Ended 30 April 2025
Notes to the Financial Statements
1. General Information
Men's Health Engineers Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15650277 . The registered office is 9 Larkspear Close, Gloucester, Gloucestershire, GL1 5LN.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.
2.3. Significant judgements and estimations
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Judgements
No significant judgements have been made by management in preparing these financial statements.
Key sources of estimation uncertainty
No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.
2.4. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.5. Intangible Fixed Assets and Amortisation - Other Intangible
Separately acquired intangible assets are stated in the balance sheet at cost less any subsequent accumulated amortisation and subsequent accumulated impairment losses.
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful economic life.
Software development costs are amortised to the profit and loss account over their estimated economic life of 5 years.
Page 4
Page 5
Men's Health Engineers Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 April 2025
2.6. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Computer Equipment | 20% Straight line

2.7. Financial Instruments
Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.
Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below. A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset's carrying amount and the present value of estimated future cash flows, discounted at the financial asset's original effective interest rate. For financial assets carried at cost less impairment, the impairment loss is the difference between the asset's carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date. Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.
2.8. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 5
Page 6
Men's Health Engineers Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 April 2025
2.9. Trade debtors
Trade debtors are amounts due from customers for goods sold in the ordinary course of business. Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.
2.10. Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.
2.11. Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Dividends
Dividend distribution to the company's shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
4. Intangible Assets

| Software development
--- | ---
| £
Cost
As at 1 May 2024 | -
Additions | 17,183
As at 30 April 2025 | 17,183
Amortisation
As at 1 May 2024 | -
Provided during the period | 3,437
As at 30 April 2025 | 3,437
Net Book Value
As at 30 April 2025 | 13,746
As at 1 May 2024 | -

Page 6
Page 7
Men's Health Engineers Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 April 2025
5. Tangible Assets

| Computer Equipment
--- | ---
| £
Cost
As at 1 May 2024 | -
Additions | 1,204
As at 30 April 2025 | 1,204
Depreciation
As at 1 May 2024 | -
Provided during the period | 241
As at 30 April 2025 | 241
Net Book Value
As at 30 April 2025 | 963
As at 1 May 2024 | -

6. Debtors

| 2025
--- | ---
| £
Due within one year
Other debtors | 1,231

7. Creditors: Amounts Falling Due Within One Year

| 2025
--- | ---
| £
Other creditors | 15,528
Taxation and social security | 18,223
| 33,751

8. Share Capital

| 2025
--- | ---
| £
Allotted, Called up and fully paid | 1

During the year 1 Ordinary share with a nominal value of £1 was issued for total consideration of £1.
Page 7